Navigation Bordeaux Population Health Research Center (BPH) - UMR 1219 par Auteur "N'TAKPE, Jean-Baptiste"
-
Chimioprophylaxie antituberculeuse primaire à l'isoniazide : une stratégie d'actualité à l’ère du tester et traiter ; revue de la littérature
MOH, Desmorys Raoul; BADJE, Anani Dodzi; KASSI, A. N. ...(Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique. vol. 70, n° 6, pp. 305-313, 2022-10-25)Article de revue -
Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation
GABILLARD, Delphine; N'TAKPE, Jean-Baptiste
; CHAIX, Marie Laure ...
(Journal of Antimicrobial Chemotherapy. vol. 76, n° 10, pp. 2666-2674, 2021-09-15)Article de revue -
Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adults
AFFI, Roseline; GABILLARD, Delphine; KOUAME, Menan Gerard
...
(HIV Medicine, 2022-01-12)Article de revue -
Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
DE CASTRO, Nathalie; CHAZALLON, Corine; N'TAKPE, Jean-Baptiste
...
(Open Forum Infectious Diseases. vol. 9, n° 12, 2022-12)Article de revueLibre accès -
Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults
MOH, Desmorys Raoul; N'TAKPE, Jean-Baptiste; GABILLARD, Delphine
...
(BMC Infectious Diseases. vol. 22, n° 1, 2022-01-29)Article de revueLibre accès -
Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts
N'TAKPE, Jean-Baptiste; GABILLARD, Delphine
; MOH, Desmorys Raoul ...
(EBioMedicine. vol. 56, pp. 102815, 2020)Article de revueLibre accès -
Higher Risk of Mortality in HIV-HBV Co-Infected Patients from Sub-Saharan Africa Is Observed at Lower CD4 \textsuperscript+ Cell Counts
KOUAME, Menan Gerard; GABILLARD, Delphine
; MOH, Raoul ...
(Antiviral Therapy. vol. 26, n° 1-2, pp. 25--33, 2021-01-01)Article de revue -
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial
DE CASTRO, Nathalie; MARCY, Olivier
; CHAZALLON, Corine ...
(The Lancet Infectious Diseases, 2021-03-02)Article de revue